Answers are grounded in this paper and cite their sources.
Reveals protective effects of islet organoids in diabetic cardiomyopathy, suggesting novel interventions.
The dynamic crosstalk between pancreatic islets and the heart plays a critical yet poorly understood role in diabetic cardiomyopathy (DCM). Here, we present a vascularized multi-organoid-on-a-chip platform that enables the perfusion co-culture of human iPSC-derived vascularized cardiac organoids (VCOs) and vascularized islet organoids (VIOs). Under a gradient of hyperglycemic stress, this system recapitulated key features of DCM, including cardiomyocyte structural disassembly and vascular dysfunction. Crucially, co-culture with functional VIOs provided substantial protection against hyperglycemia, mitigating cardiac damage by restoring metabolic and contractile gene programs. Our study establishes a modular and physiologically relevant model to dissect the dose-dependent protective role of islets in diabetic heart disease and to screen for interventions targeting inter-organ communication.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: